Predictors of first-line treatment persistence in a Portuguese cohort of relapsing-remitting multiple sclerosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Predictors of first-line treatment persistence in a Portuguese cohort of relapsing-remitting multiple sclerosis

Published:2016-11 Issue: Volume:33 Page:73-78
ISSN:0967-5868
Container-title:Journal of Clinical Neuroscience
language:en
Short-container-title:Journal of Clinical Neuroscience

Author:

Correia Inês,Marques Inês Brás,Sousa Mário,Batista Sónia,Ferreira Rogério,Nunes Carla,Macário Carmo,Cunha Luís,Sousa Lívia

Publisher

Elsevier BV

Subject

Physiology (medical),Neurology (clinical),Neurology,General Medicine,Surgery

Reference14 articles.

1. Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. IFNB Multiple Sclerosis Study Group;Neurology,1993

2. Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis. PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group;Lancet,1998

3. Multiple Sclerosis Collaborative Research Group (MSCRG): intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis;Jacobs;Ann Neurol,1996

4. Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial. The Copolymer 1 Multiple Sclerosis Study Group;Johnson;Neurology,1995

5. Stopping beta-interferon therapy in multiple sclerosis: an analysis of stopping patterns;O’Rourke;Mult Scler,2005

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real‐world persistence of multiple sclerosis disease‐modifying therapies;European Journal of Neurology;2024-04-03

2. Adherence to interferon β treatment in Kosovan multiple sclerosis registry;Italian Journal of Medicine;2024-01-09

3. Factors Associated With Disease-Modifying Therapy Adherence and Persistence in Multiple Sclerosis: A Scoping Literature Review;International Journal of MS Care;2023-09-01

4. Course of therapy in patients with active relapsing-remitting multiple sclerosis despite first-line treatment;Postępy Psychiatrii i Neurologii;2023

5. TEMPORARY REMOVAL: Efectividad, persistencia del tratamiento y seguridad a largo plazo de fingolimod en pacientes con esclerosis múltiple en la práctica habitual. Resultados del Registro de 24 meses de pacientes argentinos tratados con fingolimod (REAL);Neurología Argentina;2021-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3